Zymeworks raises target price to $34 from $32
ZYME•Truist Securities raised its target price for Zymeworks to $34 from $32.
Related News
Jazz Pharmaceuticals: Truist Securities raises target price to $286 from $281
JAZZ•
H&P expands FlexRobotics deployment with ExxonMobil to nine systems
HP•
VA selects Clear Secure for pilot to verify veterans signing in to VA.gov
YOU•
Lamb Weston Holdings: Deutsche Bank raises target price to $53 from $52
LW•
Ellington Financial declares monthly common dividend of $0.13 a share
EFC•